Search by Drug Name or NDC

NDC 00078-0668-15 Mekinist 2 mg/1 Details

Mekinist 2 mg/1

Mekinist is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is TRAMETINIB DIMETHYL SULFOXIDE.

MedlinePlus Drug Summary

Trametinib is used alone or in combination with dabrafenib (Tafinlar) to treat a certain types of melanoma (a type of skin cancer) that cannot be treated with surgery or that has spread to other parts of the body. It is used in combination with dabrafenib to treat and prevent the return of a certain type of melanoma after surgery to remove it and any affected lymph nodes. Trametinib is also used in combination with dabrafenib to treat a certain type of non-small-cell lung cancer (NSCLC) that has spread to nearby tissues or to other parts of the body. It is used in combination with dabrafenib to treat a certain type of thyroid cancer that has spread to nearby tissues or to other parts of the body, which cannot be treated with other therapies. Trametinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells. =

Related Packages: 00078-0668-15
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Trametinib

Product Information

NDC	00078-0668
Product ID	0078-0668_26a4b56c-c10d-4b34-97d2-e46d150f2043
Associated GPIs	21533570100330
GCN Sequence Number	071037
GCN Sequence Number Description	trametinib dimethyl sulfoxide TABLET 2 MG ORAL
HIC3	V3U
HIC3 Description	ANTINEOPLASTIC - MEK1 AND MEK2 KINASE INHIBITORS
GCN	34727
HICL Sequence Number	040361
HICL Sequence Number Description	TRAMETINIB DIMETHYL SULFOXIDE
Brand/Generic	Brand
Proprietary Name	Mekinist
Proprietary Name Suffix	n/a
Non-Proprietary Name	trametinib
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	2
Active Ingredient Units	mg/1
Substance Name	TRAMETINIB DIMETHYL SULFOXIDE
Labeler Name	Novartis Pharmaceuticals Corporation
Pharmaceutical Class	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA204114
Listing Certified Through	n/a

Package

NDC 00078-0668-15 (00078066815)

Pricing Information	N/A
NDC Package Code	0078-0668-15
Billing NDC	00078066815
Package	30 TABLET, FILM COATED in 1 BOTTLE (0078-0668-15)
Marketing Start Date	2016-03-17
NDC Exclude Flag	N